An Open-Label Pilot Study of Risperidone in the Treatment of Methamphetamine Dependence

Journal of Psychoactive Drugs

Volumn 39, Issue 2, 2007, Pages 167-172

  Meredith, Charles W ^a   Jaffe, Craig ^a   Yanasak, Elisia ^b   Cherrier, Monique ^a,b   Saxon, Andrew J ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Amphetamine; Methamphetamine; Neuropsychology; Risperidone; Stimulant; Treatment

Indexed keywords

METHAMPHETAMINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; DEMOGRAPHY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; FEMALE; FOLLOW UP; HANGOVER; HUMAN; MALE; NERVOUSNESS; NEUROPSYCHOLOGICAL TEST; OPEN STUDY; PILOT STUDY; PSYCHOPHARMACOLOGY; SCORING SYSTEM; SEDATION; SELF REPORT; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREMOR; VETERAN; XEROSTOMIA;

EID: 34547103009     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2007.10399875     Document Type: Article

References (43)

1. Arnt, J. 1996. Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newerantipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system? Psychopharmacology (Berlin) 124 (1-2): 117-25.
2. Arnt, J. 1992. Sertindole and several antipsychotic drugs differentially inhibit the discriminative stimulus effects of amphetamine, LSD and St 587 in rats. Behavioral Pharmacology 3 (1): 11-18.
3. Barr, A. & Brandt, J. 1996. Word-list generation deficits in dementia. Journal of Clinical and Experimenlal Neuropsychology 18 (6): 810-22.
4. Batki, S.; Moon, J.; Bradley, M.; Hersh, D.; Smolar, S.; Mengis, M.; Delucchi, K.; Sexe, D.; Bennett, S.; Lefkowitx, E.; Chu, W.; Morello, L.; Jacob, P. & Jones, R. 1999. Fluoxetine and methamphetamine dependence- A controlled trial: Preliminary analysis. In: L. Harris (Ed.) Problems of Drug Dependence 1999. NIDA Research Monograph 180. Bethesda, MD: NIDA.
5. Benedict, R.H. 1997. BriefVisual Memory Tesl - Revised. Odessa, Rorida: Psychological Assessment Resources, Inc.
6. Benedict, R.H.: Schretlen, D.; Groninger, L. & Brandt, J. 1998. Hopkins Verbal Learning Test-Revised: Normative data analysis of inter-form and test-retest reliability. Clinical Neuropsychologisl 12:43-55.
7. Bilder, R.M.; Goldman, R.S.; Volavka, J.; Czobor, P.; Hoptman, M.; Sheitman, B.; Lindenmayer, J.P.; Citrome, L.; McEvoy, J.; Kunz, M.; Chakos, M.; Cooper, TB.; Horowitz, T.L. & Liberman, J.A. 2002. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. American Journal of Psychiatry 159: 1018-28.
8. Bohus, B.: Koolhaas, J.M.; Korte, S.M.; Roozendaal, B. & Wiersma, A. 1996. Forebrain pathways and their behavioural interactions with neuroendocrine and cardiovascular function in the rat. Clinical and Experimental Pharmacology and Physiology 23 (2): 177-82.
9. Borkowski, J.G.; Benton, A.L. & Spreen, O. 1967. Word fluency and brain damage. Neuropsychologia 5: 135-40.
10. Cecchi, M.; Khoshbouei, H. & Morilak, D.A. 2002. Modulatory effects of norepinephrine, acting on alpha I receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology 43 (7): 1139-47.
11. Childress, A.R.; Mozley, P.D.; McElgin, W.; Fitzgerald, J.; Reivich, M. & O’Brien, C.P 1999. Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry 156 (1): 11-8.
12. Derogatis, L.R. & Melisaratos, N. 1983. The Brief Symptom Inventory: An introductory report. Psychological Medicine 13 (3): 595-605.
13. Erb, S; Hitchcon, P.K.; Rajabi, H.; Mueller, D.; Shaham, Y. & Stewart, J. 2000. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23 (2) 138-50.
14. Galloway, G.P.; Newmeyer, J.; Knapp, T.; Stalcup, S.A. & Smith, D. 1996. A controlled trial of imipramine for the treatment of methamphetamine dependence. Journal of Substance Abuse Treatment 13 (6): 493-7.
15. Galloway, G.P.; Newmeyer, J.; Knapp, T.; Stalcup, S.A. & Smith, D. 1994. Imipramine for the treatment of cocaine and methamphetamine dependence. Journal of Addictive Disorders 13 (4): 201-16.
16. Giros, B.; Jaber, M.; Jones, S R.; Wightman, R.M. & Caron, M.G. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (6566): 606-12.
17. Golden, J.C. 1978. Stroop Color and Word Test. Chicago, IL: Stoelting Company.
18. Grabowski, J.; Rhoades, H.; Silverman, P.; Schmitz, J.M.; Stotts, A.: Creson, D. & Bailey, R. 2000. Risperidone for the treatment of cocaine dependence: Randomized, double-blind trial. Journal of Clinical Psychopharmacology 20 (3): 305-10.
19. Grabowski, J.; Shearer, J.; Merrill, J. & Negus, S.S. 2004. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors 29 (7): 1439-64.
20. Huber, A.; Ling, W.; Shoptaw, S.; Gulati, V; Brethen, P. & Rawson, R. 1997. Integrating treatments for methamphetamine abuse: A psychosocial perspective. Journal of Addictive Disorders 16(4): 41-50.
21. Kampman, K.M.; Pettinati, H.; Lynch, K.G.; Sparkman, T. & O'Brien, C.P 2003. A pilot trial of olanzapine for the treatment of cocaine dependence. Drug and Alcohol Dependence 70 (3): 265-73.
22. Kllve, H. 1963. Grooved Pegboard. Lafayette, IN: Lafayette Instruments.
23. Koob, G.F. 1999. Corticotropin-releasing factor, norepinephrine, and stress. Biological Psychiatry 46 (9): 1167-80.
24. Little, K.Y.; Zhang, L.; Desmond, T.; Frey, K.A.; Dalack, G.W. & Cassin, B.J. 1999. Striatal dopaminergic abnormalities in human cocaine users. American Journal of Psychiatry 156 (2): 238-45.
25. Malison, R.T.; Best, S.E.; van Dyck, C.H.; McCance, E. F.; Wallace, E.A.; Laruelle, M.; Baldwin, R.M.; Seibyl, J.P.; Price, L.H.; Kosten, T.R. & Innis, R.B. 1998. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [1231] beta-CIT SPECT. American Journal of Psychiatry 155 (6): 832-34.
26. Malison, R.T.; Best, S.E.; Wallace, E.A.; McCance, E.; Laruelle, M.; Zoghbi, S.S.; Baldwin, R.M.; Seibyl, J.S.; Hoffer, P.B.; Price, L.H.; Kosten, T.R. & Innis, R.B. 1995. Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts. Psychopharmacology (Berlin) 122 (4): 358-62.
27. Mash, D.C.; Pablo, J.; Ouyang, Q.; Hearn, W.L. & Izenwasser, S. 2002. Dopamine transport function is elevated in cocaine users. Journal of Neurochemistry 81 (2): 292-300.
28. McCann, U.D.; Wong, D.F.; Yokoi, F.; Villemagne, V.; Dannals, R.F. & Ricaurte, G.A. 1998. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [I IC]WIN-35,428. Journal of Neuroscience 18 (20): 8417-22.
29. Newton, T.F.; Ling, W.; Kalechstein, A.D.; Uslaner, J. & Tervo, K. 2001. Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry Research 102 (3): 227-33.
30. Piersma, H.L.; Reaume, W.M. & Boes, J.L. 1994. The Brief Symptom Inventory (BSI) as an outcome measure for adult psychiatric inpatients. Journal of Clinical Psychology 50 (4): 555-63.
31. Reitan, R.M. & Davison, LA (Eds.) 1974. Clinical Neuropsychology: Current Status and Applications. Washington, DC: V.H. Winston & Sons.
32. Richelson, E. 1999. Receptor pharmacology of neuroleptics: Relation to clinical effects. Journal of Clinical Psychiatry 60 (Suppl 10): 5-14.
33. Rush, C.R.; Stoops, W.W.; Hays, L.R.; Glaser, PE. & Hays, L.S. 2003. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. Journal of Pharmacology and Experimental Therapeutics 306 (1): 195-204.
34. Shoptaw, S.; Rawson, R.A.; McCann, M.J. & Obert, J.L. 1994. The Matrix model of outpatient stimulant abuse treatment: Evidence of efficacy. Journal of Addictive Disorders 13 (4): 129-41.
35. Simon, S.L.; Dacey, J.; Glynn, S.; Rawson, R. & Ling, W. 2004. The effect of relapse on cognition in abstinent methamphetamine abusers. Journal of Substance Abuse Treatment 27 (I): 59-66.
36. Simon, S.L.; Richardson, K.; Dacey, J.; Glynn, S.; Domier, C.P; Rawson, R.A. & Ling, W. 2002. A comparison of patterns of methamphetamine and cocaine use. Journal of Addictive Disorders 21 (1): 35-44.
37. Stahl, S.M. & Shayegan, D.K. 2003. The psychopharmacology of ziprasidone: Receptor-binding properties and real-world psychiatric practice. Journal of Clinical Psychiatry 64 (Suppl 19): 6-12.
38. Stuber, G.D.; Roitman, M.F.; Phillips, PE.; Carelli, R.M. & Wightm, R.M. 2005. Rapid dopamine signaling in the nucleus accumbe during contingent and noncontingent cocaine administratio Neuropsychopharmacology 30 (5): 853-63.
39. Vanderschuren, L.J.; Beemster, P & Schoffelmeer, A.N. 2003. On the rc of noradrenaline in psychostimulant-induced psychomotor activi and sensitization. Psychopharmacology (Berlin) 169 (2): 176-85.
40. Volkow, N.D.; Chang, L.; Wang, G.J.; Fowler, J.S.; Leonido-Yee, V; Franceschi, D.; Sedler, M.J.; Gatley, S.J.; Hitzemann, R.; Din Y.S.; Logan, J.; Wong, C. & Miller, E.N. 2001. Association ■ dopamine transporter reduction with psychomotor impairment methamphetamine abusers. American Journal of Psychiatry 11 (3): 377-82.
41. WeickertGoldberg, T.E.; Marenco, S.; Bigelow, L.B.; Egan, M. & Weinberger, D.R. 2003. Comparison of cognitive performanci during a placebo period and an atypical antipsychotic treatmei period in schizophrenia: Critical examination of confound Neuropsychopharmacology 28: 1491-1500.
42. Weiss, F.; Ciccocioppo, R.; Parsons, L.H.; Katner, S.; Liu, X.; Zorrilla, E. I.; Valdez, G.R.; Ben-Shahar, O.; Angeletti, S. & Richter, R.R. 2004 Compulsive drug-seeking behavior and relapse. Neuroadaptatioi stress, and conditioning factors. Annals of the New York Acaden of Sciences 937: 1-26.
43. Weschler, D. 1997. WechslerAdultIntelligence Scale-Third Edition. Sa Antonio, TX: The Psychological Corporation.